吕万良团队针对乳腺癌组织屏障发展了一种双响应性纳米载体递药系统
北京大学药学院天然药物及仿生药物全国重点实验室
The research team of Prof. Wanliang Lu has developed dual-responsive nanoparticles for enhanced drug delivery in breast cancer chemotherapy
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2025, (1): 83
-83
.
>
>